Antitumor immunity

New perspective on targeting the tumor suppressor p53 pathway in the tumor microenvironment to enhance the efficacy of immunotherapy
Gang Guo, Yan Cui

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (1) 9; DOI: 10.1186/s40425-015-0053-5
Current clinical trials testing the combination of immunotherapy with radiotherapy
Josephine Kang, Sandra Demaria, Silvia Formenti

Journal for ImmunoTherapy of Cancer Dec 2016, 4 (1) 51; DOI: 10.1186/s40425-016-0156-7
An immune surveillance model to monitor the response to neo-adjuvant chemotherapy treatment in breast cancer patients
David A Bernal-Estévez, Oscar A García, Ramiro Sanchez, Carlos A Parra-López

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P261; DOI: 10.1186/2051-1426-3-S2-P261
Induction of systemic and therapeutic antitumor immunity using intratumoral injection of bone-marrow derived dendritic cells genetically modified to express interleukin 12 combined with anti-CTLA-4 antibody
Marimo Sato-Matsushita, Yoshihiro Hayakawa, Asuka Asami, Setsuko Nakayama, Hideaki Tahara

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P243; DOI: 10.1186/2051-1426-3-S2-P243
γδ T cell activation may contribute to antitumor immunity stimulated by intralesional BCG immune therapy for cutaneous melanoma metastases
Romela Ramos, Agnes Lee, Alfred Chan, Keith S Bahjat, Leland Foshag, Mark Faries, Delphine Lee, Peter Sieling

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P312; DOI: 10.1186/2051-1426-3-S2-P312
Systemic delivery of liposome-anchored anti-CD137 and IL2-Fc prevents lethal toxicity and elicits potent antitumor immunity
Yuan Zhang, Darrell J Irvine

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P318; DOI: 10.1186/2051-1426-3-S2-P318
The extent of metalloproteinase-mediated LAG3 cleavage limits the efficacy of PD1 blockade
Lawrence P Andrews, Andrea L Szymczak-Workman, Creg J Workman, Dario AA Vignali

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P216; DOI: 10.1186/2051-1426-3-S2-P216
Transduction of human dendritic cells with adenovirus encoding anti-PD-1 reduces PD-1 expression on co-cultured T cells
Santos Patricia, Etheridge Alexander, Andrea Gambotto, Lisa H Butterfield

Journal for ImmunoTherapy of Cancer Dec 2014, 2 (Suppl 3) P254; DOI: 10.1186/2051-1426-2-S3-P254
Bortezomib enhances anti-tumor T cell immunity by remodeling Notch system
Menaka Thounaojam, Duafalia Dudimah, David Carbone, Mikhail Dikov, Anil Shanker

Journal for ImmunoTherapy of Cancer Dec 2014, 2 (Suppl 3) P181; DOI: 10.1186/2051-1426-2-S3-P181
A multi-epitope melanoma helper peptide vaccine durably increases Th1 cytokine production by responding lymphocytes
Patrick M Dillon, Walter C Olson, Andrea Czarkowski, Gina R Petroni, Mark Smolkin, William W Grosh, Kimberly A Chianese-Bullock, Donna H Deacon, Craig L Slingluff

Journal for ImmunoTherapy of Cancer Nov 2013, 1 (Suppl 1) P209; DOI: 10.1186/2051-1426-1-S1-P209

Main menu

Antitumor immunity

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Antitumor immunity

Pages